INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

80,116 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Open-market purchase
BUY$98K
19.1K sh
Mar 30, 2026Mar 31, 2026
Page 1285 of 2003
← PrevNext →
traded Mar 30, 2026
+1d
SEC Form 4

Evidence

32
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,991
74 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

30
GD
Garagic DenisCHIEF TECHNOLOGY OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$84K
15.1K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

29
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$57K
1,838 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

29
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$65K
2,100 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

29
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

27
TT
Thatcher TrevorCHIEF FINANCIAL OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$17K
3,030 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

27
SS
Sonne StephenCHIEF LEGAL OFFICER
PDYNPalladyne AI Corp.
Open-market sale
SELL$19K
3,471 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

26
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$18K
558 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

26
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale · 10b5-1 plan
SELL$268K
50.0K sh
Mar 26, 2026Mar 31, 2026
traded Mar 26, 2026
+5dSEC Form 4

Evidence

26
HF
Huang Michael F.Sr. VP of Clinical Development
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$15K
488 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

25
Mark AlfordRSelf
BRK.Bsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share Berkshire Hathaway Inc. New Common Stock
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

25
HM
Hoffmann MartinCEO
ONONOn Holding AG
Option exercise
M$936K
25.0K sh
Mar 20, 2026Mar 31, 2026
traded Mar 20, 2026
+11dSEC Form 4

Evidence

25
Mark AlfordRSelf
AAPLApple Inc.
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

25
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Open-market sale
SELL$49K
9,499 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

25
BS
Bimes Randy S.Director
QNBCQNB CORP.
Open-market purchase
BUY$10,000
263 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

24
GL
Guerrero Paula LChief Information Officer
CIACITIZENS, INC.
Small acquisition
L$995
177 sh
Jan 30, 2026Mar 31, 2026
traded Jan 30, 2026
+60dSEC Form 4

Evidence

24
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$332K
68.0K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

22
SM
Scucchi MarkEVP & CFO
RRCRANGE RESOURCES CORP
Grant or award
A$2.41M
50.6K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

22
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$247K
2,161 sh
Mar 6, 2026Mar 31, 2026
traded Mar 6, 2026
+25dSEC Form 4

Evidence

22
DD
Degner DennisChief Executive Officer & Pres
RRCRANGE RESOURCES CORP
Grant or award
A$3.64M
76.3K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

22
UF
Urness Ryan FSVP, GC & Secretary
DYDYCOM INDUSTRIES INC
Tax withholding
F$1.52M
4,440 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

22
PS
Peyovich Daniel SPresident & CEO
DYDYCOM INDUSTRIES INC
Tax withholding
F$2.69M
7,862 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

21
LM
Lewis Bryon MatthewChief Operations Officer
CIACITIZENS, INC.
Option exercise
M—
2,587 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
TS
Truex SamanthaDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
VJ
VanBelle JenniferDirector
LLOEWS CORP
Grant or award
A—
235 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

21
KA
Kantoff AaronDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
KL
Kinlaw Sheryl LChief Legal Officer
CIACITIZENS, INC.
Option exercise
M—
10.9K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
TS
Truex SamanthaDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
CP
Conklin Jeffery P.CFO & Treasurer
CIACITIZENS, INC.
Option exercise
M—
12.5K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
24.2K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$3,000
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

21
KL
Kinlaw Sheryl LChief Legal Officer
CIACITIZENS, INC.
Option exercise
M—
15.2K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
PM
Preston Tracy MEVP, CLO & Corporate Secretary
MMacy's, Inc.
Option exercise
M—
7,504 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
KA
Kantoff AaronDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

21
GL
Guerrero Paula LChief Information Officer
CIACITIZENS, INC.
Option exercise
M—
3,034 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

20
Mark AlfordRSelf
SDsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share DIA - State Street SPDR Dow Jones Indust Avg ETF Trust NYSEARCA: DIA
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence

20
Mark AlfordRSelf
SPYBsold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share SPDR S&P 500 Buyback ETF
Partial sale
SELL$1,001 – $15KMar 16, 2026Mar 31, 2026
traded Mar 16, 2026
+15dHouse PTR

Evidence